During four centuries of mercurial treatment of syphilis there has been little documentary evidence of the concept of treatment-resistance in syphilis. Mercury, on account of its feeble treponemicidal action, did not interfere to any significant extent with the natural course of infection, and the question of resistance to treatment did not arise. In the decade following the introduction of the organic arsenical compounds, Ehrlich's concept of " therapia sterilisans magna" dominated the field, but Ehrlich himself foresaw the problem of drug-fastness in chemotherapy and, recognizing inadequate dosage as its most frequent cause, emphasized the dangers of under-treatment at several international conferences. From 1920 to 1940 many reports on treatment-resistant syphilis werepublished by German and French workers. Beerman (1936) lists 430 references. Most of these reports discuss resistance to arsenical therapy and some to bismuth. Silberstein (1924) classified treatment-resistance in primary and secondary syphilis as follows:
(1) Primary Resistance-resistant from the start.
(2) Primary-Secondary Resistance-after initial involution a resistant recurrence develops.
(3) Secondary Resistance-arsenical treatment heals the lesions, but after a latent period a resistant recurrence appears. Gougerot (1923 Gougerot ( , 1931 and Nicolas, Lacassagne, and Froment (1930) , cited by Beerman (1936) , give a more elaborate classification based on the degree of resistance. The increase of treatment-resistant syphilis in the pre-penicillin era was reported almost excJusively from France and Germany, the criteria of resistance being:
(a) persistence of lesions, * Received for publication August, 10 1954. (b) persistently positive blood serology tests, (c) persistence of Treponema pallidum in spite of adequate treatment, the last being the most reliable.
The most common clinical types of treatmentresistant syphilis occur in early infections and are usually cutaneous. The lesions may be typical or atypical. They are stated to have a predilection for the face, nose, neck, penis, and upper extremities, and are usually atypical at the time of their appearance. Precocious tertiarism is present in many of these cases and chancriform recurrences are frequently reported. The blood serological reaction tends to be negative more frequently in treatment-resistant early syphilis. The host seems to play the key role in treatment-resistance through inability to metabolize the drugs used, failure of defensive powers, endocrine dysfunction, hepatic insufficiency, and so on. Clinical evidence supported by in vitro laboratory studies suggests that small subcurative doses of a treponemicidal drug and inadequate treatment are more likely to cause treatmentresistance than the quality or brand of the drug used. Sometimes resistance may be overcome by changing to another drug.
The concept of drug-fast strains of Treponema pallidum is discounted by failure to transfer chemoresistance from a case of treatment-resistant syphilis to rabbits.
Before the discovery of penicillin numerous methods of circumventing treatment-resistance were advocated: raising the arseno-bismuth dosage, changing the drug, and non-specific measures such as injections of liver extract and malarial therapy. Only fever therapy gave satisfactory results. With the advent of penicillin, however, a safe and effective treatment for early syphilis resistant to arsenobismuth became available (Nelson and Duncan, 1945; Noojin and others, 1945 ; cited by Moore, 1947) . Although thousands of cases of syphilis have been treated with penicillin during the past decade, only one patient with dark-field positive primary syphilis, reported by Tyson (1945) , cited by Moore (1947) , failed to improve with 2-4mega units penicillin 25 for a period of 4 months and subsequently responded to penicillin and fever therapy. Hahn (1947) reported a case of late gummatous syphilis of the penis which failed to heal after 4-8 mega units penicillin but which responded promptly to therapy with mapharsen and bismuth. Reynolds (1948) The authors are not aware of a case similar to the following having been described in the literature. This patient has been under observation for 11 years, from August, 1943, to May, 1954 , and has been given various courses of treatment with every available form of therapy punctuated by periods of default. In April, 1949, he appeared to be clinically cured, but as he was still strongly sero-positive further malarial therapy was suggested; however, he could not be persuaded to undergo the ordeal of fever, which he had already tried in 1946, and was discharged.
After 5 years of well-being with no clinical recurrence, he again presented himself on May 15, 1954, with a fresh ulceration of the orbit of one month's duration. At the time of writing he is still under treatment with PAM and bismuth and the ulceration is healing.
The progress of this patient for over 10 years is set out in the Table. This prolonged resistance to treatment of syphilitic infection is unique in that it cannot be classified by any of the criteria outlined by various European investigators. The initial inadequate therapy of early syphilis is the basis of the subsequent evolution of the disease. After mapharsen, bismuth, and fever had failed, the resistance to therapy was broken in 1947 by the introduction of penicillin, but two fresh successive penile gummata appeared in 1948, the first of which responded promptly to mapharsen and bismuth and the second to penicillin. Then, after 5 years' freedom from symptoms, the disease broke out again. When he was examined on February 14, 1955 , the ulceration at the orbital margin had healed and there was no evidence of fresh lesions. He was still VDRL positive but showed decline from 128 to 32. 
Comment
The prolonged resistance of the infection to mapharsen, bismuth, and fever over a period of 3 years, after penicillin therapy, the subsequent response to penicillin, the three further recurrences, and the satisfactory healing of these later lesions with mapharsen, bismuth, and penicillin seem to suggest that not the drugs but the tissues of the host are responsible for treatment-resistance and recurrence. The role of the parasite in treatment-resistance is difficult to evaluate unless the chemo-resistance can be transferred to experimental animals. Summary A case of unusually prolonged, treatmentresistant syphilis with recurrences is reported. Inadequate treatment of the original infection seems to have induced an inveterate allergic sensitivity in the tissues of the host. After 3 years of resistance to prolonged concurrent therapy with mapharsen and bismuth, the lesions responded dramatically to the first course of penicillin, but new manifestations appeared at varying intervals from 4 months to 5 years after the first course of penicillin. These new lesions have healed both with the arseno-bismuth combination and with penicillin. It is not possible to foresee whether the patient will be free from further trouble. The treatment-resistant lesions were cutaneous and skeletal.
